| 000 | 01724 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517022628.0 | ||
| 264 | 0 | _c20151106 | |
| 008 | 201511s 0 0 eng d | ||
| 022 | _a0065-2598 | ||
| 024 | 7 |
_a10.1007/5584_2015_127 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDelgado, Graciela E | |
| 245 | 0 | 0 |
_aPlasma Fibrinolysis Parameters in Smokers and Non-smokers of the Ludwigshafen Risk and Cardiovascular Health (LURIC) Study. _h[electronic resource] |
| 260 |
_bAdvances in experimental medicine and biology _c2015 |
||
| 300 |
_a69-77 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xblood |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 |
_aCotinine _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFibrin Fibrinogen Degradation Products _xmetabolism |
| 650 | 0 | 4 | _aFibrinolysis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLongitudinal Studies |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPlasminogen Activator Inhibitor 1 _xblood |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 |
_aProtein C _xmetabolism |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSex Factors |
| 650 | 0 | 4 |
_aSmoking _xadverse effects |
| 650 | 0 | 4 | _aSurveys and Questionnaires |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 |
_aTissue Plasminogen Activator _xblood |
| 700 | 1 | _aSiekmeier, Rüdiger | |
| 700 | 1 | _aKrämer, Bernhard K | |
| 700 | 1 | _aMärz, Winfried | |
| 700 | 1 | _aKleber, Marcus E | |
| 773 | 0 |
_tAdvances in experimental medicine and biology _gvol. 858 _gp. 69-77 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/5584_2015_127 _zAvailable from publisher's website |
| 999 |
_c24720644 _d24720644 |
||